Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Viva Biotech Holdings
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
3,159.36 |
2,458.15 |
2,874.11 |
3,315.60 |
| Przychód Δ r/r |
0.00% |
-22.19% |
16.92% |
15.36% |
| Przychód (min) |
3,159.36 |
2,458.15 |
2,874.11 |
3,315.60 |
| Przychód (max) |
3,159.36 |
2,458.15 |
2,874.11 |
3,315.60 |
| EBITDA (średnia) |
135.22 |
105.21 |
123.01 |
141.91 |
| EBIT (średnia) |
-144.87 |
-112.71 |
-131.79 |
-152.03 |
| EBIT % |
-4.59% |
-4.59% |
-4.59% |
-4.59% |
| Zysk netto (średni) |
385.10 |
392.59 |
470.47 |
562.51 |
| Zysk netto % |
12.19% |
15.97% |
16.37% |
16.97% |
| EPS (średnia) |
0.20 |
0.14 |
0.16 |
0.20 |
| Liczba analityków (Przychody) |
1 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
1 |
1 |
| symbol |
1873.HK |
1873.HK |
1873.HK |
1873.HK |